X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ophthalmology (8) 8
humans (6) 6
bevacizumab (5) 5
tomography, optical coherence (5) 5
aged (4) 4
female (4) 4
fluorescein angiography (4) 4
index medicus (4) 4
macular degeneration (4) 4
male (4) 4
middle aged (4) 4
visual acuity (4) 4
aged, 80 and over (3) 3
angiogenesis inhibitors - administration & dosage (3) 3
angiogenesis inhibitors - therapeutic use (3) 3
clinical trials (3) 3
diabetic retinopathy - diagnosis (3) 3
drug therapy (3) 3
endothelial growth-factor (3) 3
eye diseases (3) 3
intravitreal injections (3) 3
physiological aspects (3) 3
ranibizumab (3) 3
retrospective studies (3) 3
vascular endothelial growth factor a - antagonists & inhibitors (3) 3
angiogenesis inhibitors (2) 2
antibodies, monoclonal - administration & dosage (2) 2
antibodies, monoclonal - adverse effects (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antibodies, monoclonal, humanized (2) 2
antibodies, monoclonal, humanized - therapeutic use (2) 2
care and treatment (2) 2
choroidal neovascularization - diagnosis (2) 2
choroidal neovascularization - drug therapy (2) 2
choroidal neovascularization - physiopathology (2) 2
comparative analysis (2) 2
diabetic retinopathy - drug therapy (2) 2
follow-up studies (2) 2
genetic structures (2) 2
injection (2) 2
injections (2) 2
macular edema - diagnosis (2) 2
pharmacokinetics (2) 2
prospective studies (2) 2
retina - pathology (2) 2
retinopathy (2) 2
tissue-plasminogen activator (2) 2
vascular endothelial growth factor a - immunology (2) 2
visual acuity - physiology (2) 2
vitreous body (2) 2
wet macular degeneration - drug therapy (2) 2
3-year (1) 1
abridged index medicus (1) 1
adult (1) 1
analysis (1) 1
angiogenesis inhibitors - adverse effects (1) 1
antibodies, monoclonal - immunology (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
architects (1) 1
architecture (1) 1
article (1) 1
bevacizumab monotherapy (1) 1
capillary permeability - drug effects (1) 1
cemeteries (1) 1
choroidal neovascular lesions (1) 1
choroidal neovascularization - etiology (1) 1
cicatrix - diagnosis (1) 1
coherence tomography findings (1) 1
cohort studies (1) 1
consulting services (1) 1
cremation (1) 1
degeneration (1) 1
design (1) 1
dexamethasone (1) 1
dexamethasone - administration & dosage (1) 1
diabetes (1) 1
diabetic retinopathy (1) 1
diabetic retinopathy - complications (1) 1
diabetic retinopathy - physiopathology (1) 1
diabetic retinopathy - surgery (1) 1
disease (1) 1
dosage and administration (1) 1
dose-response relationship, drug (1) 1
drug therapy, combination (1) 1
edema (1) 1
environmental regulations (1) 1
fab (1) 1
factor antibody fragment (1) 1
flue gas (1) 1
fovea centralis (1) 1
gases (1) 1
geographic atrophy - physiopathology (1) 1
glucocorticoids - administration & dosage (1) 1
intravitreal implant (1) 1
intravitreal ranibizumab (1) 1
intravitreal triamcinolone acetonide (1) 1
iris - blood supply (1) 1
iris neovascularization (1) 1
ischemia (1) 1
iso standards (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Ophthalmology, ISSN 0161-6420, 2015, Volume 122, Issue 2, pp. 391 - 398.e5
Journal Article
by Jampol, Lee M and Glassman, Adam R and Liu, Danni and Liu, Judy C and Aiello, Lloyd Paul and Aiello, Lloyd P and Bressler, Neil M and Bressler, Susan B and Duh, Elia J and Quaggin, Susan and Wells, Michael B and Wells, John A and Wykoff, Charles C and Browning, David and Antoszyk, Andrew N and Antoszyk, Andrew and Price, Randall L and Price, Angela K and Price, Paula A and Fredenberg, Sherry L and Herby, Jenna T and Fleming, Christina J and McClain, Ashley A and McClain, Ashley and McClain, Donna and Ennis, Sarah A and Gallagher, Kelly R and Karow, Angella S and Grupp, Autumn C and Puskas, Danielle and Watson, Brandun and Watson, Lynn and Bojaj, Swann J and Balasubramaniam, Uma M and Styles, Donna R and Kuopus, Jeff A and Kimrey, Kathryn and Clark, Mark D and Clark, Loraine M and Clark, W. Lloyd and Jackson, Lisa A and McOwen, Michael D and Dunlap, Matt and Held, Susannah J and Pieramici, Dante J and Nasir, Ma'an A and Castellarin, Alessandro A and Dhoot, Dilsher and Fishbein, Sarah and Giust, Jack and Giust, Matthew and Wan, Lisha and Hanna, Michelle S and Rabena, Melvin D and Smith, Veronica A and Smith, Jerry and Smith, Christopher M and Smith, Bradley T and Bone, Layne J and Avery, Kelly and Walker, Aimee and Walker, Joseph P and Walker, Cathy and Shook, Aimee H and Esau, Sara and Ruvalcaba, Nitce L and Johnson, Tametha and Johnson, Melissa L and Johnson, David L and Johnson, Marilyn A and Johnson, Britta and Johnson, Paula A and Payne, John F and Swinford, Tiffany R and Taylor, Mallie M and Taylor, Gena and Taylor, Teresa and Garrison, Cassandra L and Miller, Heather R and Miller, Pam S and Miller, Peggy D and Miller, David T and Miller, David G and Houlahan, Amber R and O'Neill, Charlotte A and Floyd, Geri L and Floyd, Ashley and Parker, Marianne and Parker, Crystal C and Sease, Courtney and Graham, Margie and Graham, Tara and Spencer, Robin and Ogbuewu, Tiffany N and Studebaker, Ashley and Huggins, Meagan L and Huggins, Tyler and Spivey, Robbin and Jones, Brian and Jones, Michael Cullen and ... and Diabet Retinopathy Clinical Res Ne and Diabetic Retinopathy Clinical Research Network
Ophthalmology, ISSN 0161-6420, 07/2018, Volume 125, Issue 7, pp. 1054 - 1063
To assess systemic vascular endothelial growth factor (VEGF)-A levels after treatment with intravitreous aflibercept, bevacizumab, or ranibizumab.... 
METAANALYSIS | PHARMACOKINETICS | BEVACIZUMAB | INJECTION | OPHTHALMOLOGY | RETINOPATHY | SERUM | RANIBIZUMAB | PREMATURITY | DEGENERATION
Journal Article
Ophthalmology, ISSN 0161-6420, 2006, Volume 113, Issue 3, pp. 363 - 372.e5
To report the short-term safety, biologic effect, and a possible mechanism of action of intravitreal bevacizumab in patients with neovascular age-related... 
VERTEPORFIN | TISSUE-PLASMINOGEN ACTIVATOR | PHOTODYNAMIC THERAPY | PHARMACOKINETICS | FACTOR ANTIBODY FRAGMENT | INJECTION | COHERENCE TOMOGRAPHY FINDINGS | DISEASE | OPHTHALMOLOGY | ENDOTHELIAL GROWTH-FACTOR | SUBFOVEAL CHOROIDAL NEOVASCULARIZATION | Retina - drug effects | Choroidal Neovascularization - diagnosis | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Choroidal Neovascularization - etiology | Male | Retinal Detachment - drug therapy | Macular Degeneration - diagnosis | Macular Degeneration - drug therapy | Bevacizumab | Antibodies, Monoclonal, Humanized | Choroidal Neovascularization - drug therapy | Retinal Detachment - diagnosis | Aged, 80 and over | Vitreous Body | Female | Retrospective Studies | Antibodies, Monoclonal - immunology | Fluorescein Angiography | Macular Degeneration - physiopathology | Tomography, Optical Coherence | Fovea Centralis | Macular Degeneration - complications | Vascular Endothelial Growth Factor A - immunology | Visual Acuity | Choroidal Neovascularization - physiopathology | Pigment Epithelium of Eye | Injections | Antibodies, Monoclonal - administration & dosage | Papilledema - diagnosis | Aged | Retina - pathology | Papilledema - drug therapy | Macular degeneration | Physiological aspects | Eye diseases | Angiogenesis inhibitors
Journal Article
Ophthalmology, ISSN 0161-6420, 2006, Volume 113, Issue 10, pp. 1695 - 1705.e6
Journal Article